Obesity and overweight affect millions worldwide, often posing significant health risks and diminishing quality of life. The MEDVi GLP-1 Program offers a modern, doctor-led telehealth solution designed to address these challenges using clinically proven GLP-1 receptor agonists like Semaglutide...